Elanco Animal Health Inc (NYSE: ELAN) is -18.52% lower on its value in year-to-date trading and has touched a low of $11.40 and a high of $18.80 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ELAN stock was last observed hovering at around $12.10 in the last trading session, with the day’s gains setting it 0.04%.
Currently trading at $12.14, the stock is -5.64% and -8.04% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.46 million and changing 0.33% at the moment leaves the stock -16.87% off its SMA200. ELAN registered -11.84% loss for a year compared to 6-month loss of -33.41%. The firm has a 50-day simple moving average (SMA 50) of $13.252 and a 200-day simple moving average (SMA200) of $14.62275.
The stock witnessed a -13.53% gain in the last 1 month and extending the period to 3 months gives it a -15.05%, and is -5.75% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.27% over the week and 3.48% over the month.
Elanco Animal Health Inc (ELAN) has around 9800 employees, a market worth around $5.77B and $4.45B in sales. Current P/E ratio is 29.71 and Fwd P/E is 13.34. Profit margin for the company is 4.60%. Distance from 52-week low is 6.49% and -35.43% from its 52-week high. The company has generated returns on investments over the last 12 months (1.89%).
The EPS is expected to grow by 2.89% this year.
Elanco Animal Health Inc (ELAN) Top Institutional Holders
540.0 institutions hold shares in Elanco Animal Health Inc (ELAN), with institutional investors hold 99.65% of the company’s shares. The shares outstanding are 494.33M, and float is at 486.97M with Short Float at 3.20%. Institutions hold 98.95% of the Float.
The top institutional shareholder in the company is DODGE & COX with over 83.58 million shares valued at $1.21 billion. The investor’s holdings represent 16.9471% of the ELAN Shares outstanding. As of 2024-06-30, the second largest holder is PRIMECAP MANAGEMENT CO/CA/ with 52.8 million shares valued at $761.94 million to account for 10.7062 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 49.45 million shares representing 10.0259% and valued at over $713.53 million, while PRICE T ROWE ASSOCIATES INC /MD/ holds 5.6909 of the shares totaling 28.07 million with a market value of $405.02 million.
Elanco Animal Health Inc (ELAN) Insider Activity
The most recent transaction is an insider purchase by Harrington Michael J, the company’s Director. SEC filings show that Harrington Michael J bought 3,500 shares of the company’s common stock on Aug 22 ’24 at a price of $14.85 per share for a total of $51974.0. Following the purchase, the insider now owns 81094.0 shares.
Elanco Animal Health Inc disclosed in a document filed with the SEC on Aug 12 ’24 that Simmons Jeffrey N (PRESIDENT, CEO AND DIRECTOR) bought a total of 100,000 shares of the company’s common stock. The trade occurred on Aug 12 ’24 and was made at $13.01 per share for $1.3 million. Following the transaction, the insider now directly holds 0.14 million shares of the ELAN stock.
Still, SEC filings show that on May 21 ’24, DOYLE WILLIAM F (Director) acquired 15,000 shares at an average price of $16.98 for $0.25 million. The insider now directly holds 76,330 shares of Elanco Animal Health Inc (ELAN).
